G. Donaldson (London, United Kingdom), M. Tercelj-Zorman (Ljubljana, Slovenia)
Clinically in-apparent chlamydia infections are associated with chronic obstruction and persistent inflammation of peripheral airways (animal model)
J. Jaeger, E. Liebler-Tenorio, N. Kirschvink, G. Becher, F. Melzer, P. Reinhold (Jena, Berlin, Germany; Namur, Belgium)
|  |
Chlamydophila spp. infection in horses with recurrent airway obstruction shows similarities to human chronic obstructive pulmonary disease
D. Theegarten, B. Mentrup, K. Fey, H. Hotzel, K. Sachse, O. Anhenn (Essen, Giessen, Jena, Germany)
| |
Antiapoptotic and proinflammatory function of toll-like receptor 2 in acute C. pneumoniae infection of COPD lung tissue
G. Wu, D. Droemann, T. Goldmann, J. Rupp, E. Vollmer, P. Zabel, K. Dalhoff (Luebeck, Borstel, Germany)
| |
Bronchial biopsies cells count in smokers and nonsmokers in COPD exacerbation
S. V. Nesterovich, E. B. Bukreeva (Tomsk, Russian Federation)
| |
Cytokine profile of blood and sputum in COPD exacerbation
E. B. Bukreeva, S. V. Nesterovich (Tomsk, Russian Federation)
| |
Which is the first choice antimicrobial treatment in acute exacerbation of COPD (AECOPD) requiring non-invasive mechanical ventilation (NIV)?
R. Serini, G. Cappiello, M. R. De Carlo, M. Monelli, L. M. Fabbri, M. Moretti (Modena, Italy)
| |
Bacterial flora in sputum and relationship with lung function in patients with acute exacerbation of COPD
C. Tudose, O. Dorobat, D. Ionita, D. Bumbacea, C. Toma, S. Dumitrache-Rujinski, K. Serban, M. Bogdan (Bucharest, Romania)
| |
Effectiveness of 23-valent pneumococcal polysaccharide vaccine in preventing lower respiratory tract infections complicating chronic respiratory failure
M. Sumitani, Y. Tochino, T. Kamimori, H. Fujiwara, T. Fujikawa (Osaka City, Japan)
| |
Bacterial infection-a common cause of acute exacerbation of chronic obstructive pulmonary disease (COPD)
A. M. V. Trailescu, G. I. Apti, R. M. Bacaru, O. I. Nicolaescu (Bucharest, Constantza, Romania)
| |
Infectional factors influences on expressiveness of inflammatory process and structural changes in bronchial mucosa at COPD patients
E. B. Bukreeva, S. V. Nesterovich, B. V. Shilov, L. V. Gudkova, T. G. Melnik (Tomsk, Russian Federation)
| |
Interrelationship between clinical symptoms expressiveness and brush-biopsy cell count in smokers and nonsmokers with COPD
E. B. Bukreeva, S. V. Nesterovich, B. V. Shilov, R. I. Pleshko (Tomsk, Russian Federation)
| |
The role of viruses in COPD exacerbation
E. B. Bukreeva, S. V. Nesterovich (Tomsk, Russian Federation)
| |
The role of chlamydophila pneumoniae infection of airways in patients with chronic bronchitis
I. E. Stepanyan, S. A. Kasimtseva, O. V. Lovacheva, E. E. Larionova, L. A. Gorelova (Moscow, Russian Federation)
| |
Monocyte/macrophage killing of nontypeable haemophilus influenzae
P. T. King, P. W. Holmes, J. Ngui, R. Robins-Browne, S. R. Holdsworth (Melbourne, Australia)
| |
The nasal decongestant oxymetazoline and zinc both inhibit production of pro-inflammatory cytokines in bone marrow-derived mast cells
L. Hueltner, M. Tschaikin, S. Koelsch (Neuherberg/Munich, Darmstadt, Germany)
| |
Streptococcus pneumoniae leads to secretion of VEGF by macrophages and affects angiogenesis processes
H. Golpon, C. Sauer, M. Schael, T. Nyguen, T. Welte (Hannover, Germany)
| |
Interaction between streptococcus pneumoniae and human lung cells in an acute tissue infection model
F. Xu, J. Rupp, D. Droemann, T. Goldmann, M. Maass, P. Zabel, K. Dalhoff (Luebeck, Borstel, Germany; Hangzhou, China)
| |
Adherence of S. pneumoniae in rats exposed to graded cigarette smoke for different durations
T. Ozlu, I. Celik, F. Oztuna, Y. Bulbul, S. Ozsu (Trabzon, Turkey)
| |
Functional correlations between bronchial brush-biopsy composition and proteinases and its inhibitors in sputum in smokers and nonsmokers with COPD
E. B. Bukreeva (Tomsk, Russian Federation)
| |
Seroprevalence of chlamydophila pneumoniae in patients with moderate exacerbation of COPD
O. N. Brodskaya, A. V. Averianov, Y. S. Lebedin (Moscow, Russian Federation)
| |